Kerry Corrigan is an Associate in Goodwin’s Technology and Life Sciences group. Kerry is a legal and business advisor to innovative, high-growth companies and their investors at all stages of the corporate life cycle. She advises on a broad range of corporate matters with a focus on companies in the technology and life sciences sectors, and has particular experience advising on venture capital investments/exits, corporate finance and reorganisations, as well as general corporate matters.
Prior to joining Goodwin, Kerry was an Associate at Cooley.
Experience
- Cytospire Therapeutics on its oversubscribed $83 million Series A financing
- Lightspeed Venture Partners on co-leading the $1.1 billion investment round into Ineffable Intelligence
- Lowercarbon on co-leading the $70 million financing round of Fuse Energy, valuing the company at $5 billion
Areas of Practice
Credentials
Education
Legal Practice Course2016
BPP Law School, London
LLB2015
University of Manchester
Admissions
Bars
- England and Wales